Pharmaceutical industry risks analysis and discussions. Learn more about the threats to pharmaceutical industry and opportunities. Enterprise risk management pharmaceutical industry risks tips advice and support. Access latest pharmaceutical industry news headlines opinions and risk reviews. Network with local and globally leaders in the pharmaceutical industry.
Enter code #PharmaceuticalIndustryRisks
Register for free to receive bulletins on the pharmaceutical industry
Enter code #PharmaceuticalRisks
An Unexplained Illness To A UK Participant In Leading Coronavirus Vaccine Trial By AstraZeneca and Oxford University Has Sparked a Greater Understanding Of The Potential Of Vaccine Trials To Fail At Even Relatively Advanced Stages
The pause in Astrazeneca vaccine trial is not fatal. Indeed pauses to enable investigation of illnesses in participants in trials is fairly common and a good safety measure. However it can also be fatal as is evidenced by fall in value of AstraZeneca share value.
More widely it is a salutatory reminder that we may not be as close to a solution to the coronavirus pandemic as everybody hopes.
30th April 2020 British Researchers Thought To Be Leading The Race To Find A Vaccine For Coronavirus Covid19 Agrees To Work With Leading Pharmaceutical Company To Distribute Vaccine Worldwide
The University of Oxford has agreed to work with AstraZenenca for the development manufacture and worldwide distribution of the Covid19 vaccine candidate that is currently undergoing human clinical trials in the UK.
Human trials of the vaccine developed by Oxford University’s Jenner Institute began last week. The UK government has given the institute £20 million to support the research into the vaccine.
Both partners have agreed to operate on a not for profit basis for the duration of the pandemic with only the costs of production and distribution being covered.
There is agreement in the pharmaceutical industry to help one another with vaccine production and that the intention is to supply the vaccine free of charge during the pandemic.
Promote and market your business on pharmaceutical industry risks forum for 12 months
Put your products or services in front of key business decision makers already interested in your type of business offering.
Increase the sources of your revenue streams more sustainably. Grow your business faster with BusinessRiskTV.
Do you work in the pharmaceutical industry?
Could pharmaceutical industry business risks be managed better? Want to increase pharmaceutical business revenue streams?
Pharmaceutical industry businesses face significant threats to profitable trading including regulatory compliance which means that research and development returns of pharmaceutical firms restrict opportunities for organic business growth.
BusinessRiskTV looks for solutions and risk management strategies to help increase drug development pipeline whilst reducing costs to generate sustainable profits.
Learn how to have more confidence in pharmaceutical business commercial success and reduce the cost of launching new products.
- Become more dynamic and more profitable
- Get more bang for your buck!
- Make the complex uncomplicated
Join the debates and discussions on pharmaceutical industry risks management.
Pharmaceutical Industry Business Risk Management Forum
The global need for innovative, cost effective medicines continues to rise while regulators, payers, health care providers and patients are demanding greater value for money, proven effectiveness of products, more transparency and access to information.
How do you improve business productivity and profitability in the face of the high costs of RandD and increasing expectations of the consumer to pay less? Improve the performance of your pharmaceutical business.
Subscribe to BusinessRiskTV
Read and watch more healthcare related risk management articles and videos
#BusinessRiskTV #PharmaceuticalRisks #PharmaceuticalForum #PharmaceuticalReview #PharmaceuticalReports #PharmaceuticalIndustry #Parma #Pharmaceuticals #ClinicalTrials #BioTech #MedicalDevices #Healthcare #PharmaceuticalNews #PharmaceuticalIndustryForumMarketing